Clinical trials
Prostatic Neoplasms trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
| Completed | 20 |
| Active, not recruiting | 10 |
| Not yet recruiting | 4 |
| Withdrawn | 3 |
| Terminated | 2 |
| Unknown status | 2 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 36 |
| The University of Hong Kong | 5 |
| AstraZeneca | 3 |
| PROCEPT BioRobotics | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Astellas Pharma Singapore Pte. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 64 |
| Breast Neoplasms | 2 |
| Neoplasms | 2 |
| Prostatic Hyperplasia | 2 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Central Nervous System Neoplasms | 1 |
| Cholangiocarcinoma | 1 |
| Chondrosarcoma | 1 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.